A citation-based method for searching scientific literature

Naohiro Taira, Eriko Atsumi, Saori Nakachi, Reika Takamatsu, Tomofumi Yohena, Hidenori Kawasaki, Tsutomu Kawabata, Naoki Yoshimi. Lung Cancer 2018
Times Cited: 9







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The difference in relationship between 18F-FDG uptake and clinicopathological factors on thyroid, esophageal, and lung cancers.
Hayato Kaida, Akihiko Kawahara, Masanobu Hayakawa, Satoshi Hattori, Seiji Kurata, Kiminori Fujimoto, Koichi Azuma, Yasumitsu Hirose, Shinzo Takamori, Yuji Hiromatsu,[...]. Nucl Med Commun 2014
12
22

GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer.
Jing Yang, Jing Wen, Tian Tian, Zhongsheng Lu, Yao Wang, Zikai Wang, Xiangdong Wang, Yunsheng Yang. Oncotarget 2017
35
22

Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?
Woo Hee Choi, Ie Ryung Yoo, Joo Hyun O, Tae Jung Kim, Kyo Young Lee, Young Kyoon Kim. Technol Health Care 2015
13
22

Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
Chao-Hua Chiu, Yi-Chen Yeh, Ko-Han Lin, Yu-Chun Wu, Yu-Chin Lee, Teh-Ying Chou, Chun-Ming Tsai. J Thorac Oncol 2011
37
22

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
302
22

Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Jinyu Gu, Hirofumi Yamamoto, Hiroki Fukunaga, Katsuki Danno, Ichiro Takemasa, Masataka Ikeda, Mitsuaki Tatsumi, Mitsugu Sekimoto, Jun Hatazawa, Tsunehiko Nishimura,[...]. Dig Dis Sci 2006
64
22

Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Sun Och Yoon, Tae Joo Jeon, Joon Seong Park, Yong Hoon Ryu, Jae-Hoon Lee, Jung Sik Yoo, Jae Keun Kim, Dong Sup Yoon, Eun Ji Oh. Clin Nucl Med 2015
10
22


Correlation between tumor glucose metabolism and multiparametric functional MRI (IVIM and R2*) metrics in cervical carcinoma: Evidence from integrated 18 F-FDG PET/MR.
Zhang Li-Ou, Sun Hong-Zan, Bai Xiao-Xi, Chen Zhong-Wei, Lu Zai-Ming, Xin Jun, Guo Qi-Yong. J Magn Reson Imaging 2019
3
66

Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients.
Gaowa Sharen, Yaojun Peng, Haidong Cheng, Yang Liu, Yonghong Shi, Jian Zhao. Oncotarget 2017
27
22

Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size.
Naohisa Suzawa, Morihiro Ito, Shanlou Qiao, Katsunori Uchida, Motoshi Takao, Tomomi Yamada, Kan Takeda, Shuichi Murashima. Lung Cancer 2011
55
22

Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor.
Katrin Singer, Michael Kastenberger, Eva Gottfried, Christine G Hammerschmied, Maike Büttner, Michael Aigner, Barbara Seliger, Bernhard Walter, Hans Schlösser, Arndt Hartmann,[...]. Int J Cancer 2011
83
22

The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V Liberti, Jason W Locasale. Trends Biochem Sci 2016
22

The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
22

Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
Tineke W H Meijer, Olga C J Schuurbiers, Johannes H A M Kaanders, Monika G Looijen-Salamon, Lioe-Fee de Geus-Oei, Ad F T M Verhagen, Jasper Lok, Henricus F M van der Heijden, Saskia E Rademakers, Paul N Span,[...]. Lung Cancer 2012
76
22

Meta-DiSc: a software for meta-analysis of test accuracy data.
Javier Zamora, Victor Abraira, Alfonso Muriel, Khalid Khan, Arri Coomarasamy. BMC Med Res Methodol 2006
11

Relationship between clinicopathological factors and fluorine-18-fluorodeoxyglucose uptake in patients with papillary thyroid cancer.
Hayato Kaida, Yuji Hiromatsu, Seiji Kurata, Akihiko Kawahara, Satoshi Hattori, Tomoki Taira, Maiko Kobayashi, Masafumi Uchida, Kentaro Yamada, Hiroyuki Mihashi,[...]. Nucl Med Commun 2011
19
11

Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
Andrew Evans, Victoria Bates, Helen Troy, Stephen Hewitt, Susan Holbeck, Yuen-Li Chung, Roger Phillips, Marion Stubbs, John Griffiths, Rachel Airley. Cancer Chemother Pharmacol 2008
57
11

Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.
Tetsuji Kurokawa, Yoshio Yoshida, Kazumi Kawahara, Tatsuro Tsuchida, Hidehiko Okazawa, Yasuhisa Fujibayashi, Yoshiharu Yonekura, Fumikazu Kotsuji. Int J Cancer 2004
119
11

Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma.
Nina V Chaika, Fang Yu, Vinee Purohit, Kamiya Mehla, Audrey J Lazenby, Dominick DiMaio, Judy M Anderson, Jen Jen Yeh, Keith R Johnson, Michael A Hollingsworth,[...]. PLoS One 2012
68
11


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
11

Regulation of the Warburg effect in early-passage breast cancer cells.
Ian F Robey, Renu M Stephen, Kathy S Brown, Brenda K Baggett, Robert A Gatenby, Robert J Gillies. Neoplasia 2008
83
11

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Surendra K Shukla, Vinee Purohit, Kamiya Mehla, Venugopal Gunda, Nina V Chaika, Enza Vernucci, Ryan J King, Jaime Abrego, Gennifer D Goode, Aneesha Dasgupta,[...]. Cancer Cell 2017
42
11

Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.
Anouk van Berkel, Jyotsna U Rao, Benno Kusters, Tuna Demir, Eric Visser, Arjen R Mensenkamp, Jeroen A W M van der Laak, Egbert Oosterwijk, Jacques W M Lenders, Fred C G J Sweep,[...]. J Nucl Med 2014
46
11

Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
Seok Gun Park, Jai Hyuen Lee, Won Ae Lee, Kang Min Han. Nucl Med Biol 2012
39
11

Noninvasive evaluation of 18F-FDG/18F-FMISO-based Micro PET in monitoring hepatic metastasis of colorectal cancer.
Mingyu Zhang, Huijie Jiang, Rongjun Zhang, Hailong Xu, Hao Jiang, Wenbin Pan, Xin Li, Yiqiao Wang, Song Wang. Sci Rep 2018
7
14

Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
Yecai Huang, Mei Feng, Qiao He, Jun Yin, Peng Xu, Qinghua Jiang, Jinyi Lang. Medicine (Baltimore) 2017
17
11



Evaluation of Glucose Uptake in Normal and Cancer Cell Lines by Positron Emission Tomography.
Francesca Maddalena, Giacomo Lettini, Rosj Gallicchio, Lorenza Sisinni, Vittorio Simeon, Anna Nardelli, Angela Assunta Venetucci, Giovanni Storto, Matteo Landriscina. Mol Imaging 2015
9
11

Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.
Koji Kitamura, Etsuro Hatano, Tatsuya Higashi, Masato Narita, Satoru Seo, Yuji Nakamoto, Kenya Yamanaka, Hiromitsu Nagata, Kojiro Taura, Kentaro Yasuchika,[...]. J Hepatol 2011
96
11


Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT.
Yoshiharu Ohno, Hisanobu Koyama, Keiko Matsumoto, Yumiko Onishi, Daisuke Takenaka, Yasuko Fujisawa, Takeshi Yoshikawa, Minoru Konishi, Yoshimasa Maniwa, Yoshihiro Nishimura,[...]. Radiology 2011
82
11

A new dimension of FDG-PET interpretation: assessment of tumor biology.
Thomas C Kwee, Sandip Basu, Babak Saboury, Valentina Ambrosini, Drew A Torigian, Abass Alavi. Eur J Nucl Med Mol Imaging 2011
61
11

FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.
T Mochizuki, E Tsukamoto, Y Kuge, K Kanegae, S Zhao, K Hikosaka, M Hosokawa, M Kohanawa, N Tamaki. J Nucl Med 2001
202
11

Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Tomohiro Yamada, Moritoshi Uchida, Kang Kwang-Lee, Naoya Kitamura, Tomohide Yoshimura, Eri Sasabe, Tetsuya Yamamoto. Oral Surg Oral Med Oral Pathol Oral Radiol 2012
45
11

Biological correlates of FDG uptake in non-small cell lung cancer.
Lioe-Fee de Geus-Oei, J Han J M van Krieken, Riena P Aliredjo, Paul F M Krabbe, Cathelijne Frielink, Ad F T Verhagen, Otto C Boerman, Wim J G Oyen. Lung Cancer 2007
145
11

FDG-PET in Mediastinal Nodal Staging of Non-small Cell Lung Cancer: Correlation of False Results with Histopathologic Finding.
Hee Jong Baek, Jin Haeng Chung, Jong Ho Park, Jae Ill Zo, Gi Jeong Cheon, Chang Woon Choi, Sang Moo Lim, Soo Yong Choi, Jong Myeon Hong, Jang Soo Hong. Cancer Res Treat 2003
1
100


Correlation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesions.
Zhen Guang Wang, Ming Ming Yu, Yu Han, Feng Yu Wu, Guang Jie Yang, Da Cheng Li, Si Min Liu. Medicine (Baltimore) 2016
10
11

Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation.
Hai-Jing Yang, Wei-Jia Xu, Yi-Hui Guan, Hui-Wei Zhang, Wei-Qun Ding, Lan Rong, Zhi-Bing Qiu, Liang Zhong. Transl Oncol 2016
13
11

[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.
Marcelo Mamede, Tatsuya Higashi, Masanori Kitaichi, Koichi Ishizu, Takayoshi Ishimori, Yuji Nakamoto, Kazuhiro Yanagihara, Mio Li, Fumihiro Tanaka, Hiromi Wada,[...]. Neoplasia 2005
184
11

No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.
N Charnley, R Airley, D Du Plessis, C West, C Brock, C Barnett, J Matthews, K Symonds, M Bottomly, R Swindell,[...]. Oncol Rep 2008
8
12


Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.
I-Lu Lai, Chih-Chien Chou, Po-Ting Lai, Chun-Sheng Fang, Lawrence A Shirley, Ribai Yan, Xiaokui Mo, Mark Bloomston, Samuel K Kulp, Tanios Bekaii-Saab,[...]. Carcinogenesis 2014
34
11

Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer.
K Higashi, Y Ueda, A Sakurai, X Mingwang, L Xu, M Murakami, H Seki, M Oguchi, S Taki, Y Nambu,[...]. Eur J Nucl Med 2000
133
11


Predictive value of glucose transporter-1 and glucose transporter-3 for survival of cancer patients: A meta-analysis.
Xiu Chen, Peng Lu, Siying Zhou, Lei Zhang, Jian-Hua Zhao, Jin-Hai Tang. Oncotarget 2017
23
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.